|  | n | (%) |
---|---|---|---|
All patients | Â | 33 | 100 |
Gender | Male | 32 | (97) |
 | Female | 1 | (3) |
Age (median, 53 years) | |||
 | 36–40 | 1 | (3) |
 | 41–50 | 10 | (30) |
 | 51–60 | 15 | (46) |
 | 61–70 | 7 | (21) |
Tumor site | Tonsils | 8 | (24) |
 | Oropharynx | 12 | (36) |
 | Hypopharynx | 5 | (16) |
 | Mouth | 8 | (24) |
pTN category | T1 N2 | 7 | (21) |
 | T1 N3 | 1 | (3) |
 | T2 N0 | 1 | (3) |
 | T2 N1 | 2 | (6) |
 | T2 N2 | 5 | (16) |
 | T3 N1 | 1 | (3) |
 | T3 N2 | 5 | (16) |
 | T4 N0 | 1 | (3) |
 | T4 N1 | 1 | (3) |
 | T4 N2 | 6 | (19) |
 | TX N1 | 1 | (3) |
 | TX N2 | 2 | (6) |
AJCC Stage | I | 0 | (0) |
 | II | 1 | (3) |
 | III | 4 | (12) |
 | IV | 28 | (84) |
p16 Status | positive | 10 | (31) |
 | negative | 22 | (69) |